Comparison of the efficacy and safety of transarterial chemoembolization with and without apatinib for the treatment of BCLC Stage C hepatocellular carcinoma

被引：0
|
作者：
Chen, S. [1 ,2 ]
机构：
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Canc Hosp, Dept Intervent Oncol, Fuzhou, Fujian, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
379 (PB-04
引用
收藏
页码：E123 / E123
页数：1
相关论文
共 50 条
  • [31] Efficacy and its impact on overall survival of transarterial chemoembolization (TACE) combined with Lenvatinib in hepatocellular carcinoma patients belonging to BCLC stage C
    Rahman, A.
    Sahoo, B.
    Mishra, S. K.
    Panigrahy, M.
    Nayak, M. K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1466 - S1466
  • [32] Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study
    Liu, Changfu
    Xing, Wenge
    Si, Tongguo
    Yu, Haipeng
    Guo, Zhi
    ONCOTARGET, 2017, 8 (59) : 100734 - 100745
  • [33] Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular Carcinoma
    Zhou, Wen-Jie
    Huang, Jin-Tao
    Lu, Xin
    Hu, Di
    Hong, Xin
    Wang, Fu-An
    Lv, Peng-Hua
    Zhu, Xiao-Li
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 2515 - 2524
  • [34] Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma
    Gao Heng-jun
    Zhang Yao-jun
    Chen Min-shan
    Chen Mei-xian
    Huang Jun-ting
    Xu Li
    Lau, Wan Y.
    LIVER INTERNATIONAL, 2014, 34 (04) : 612 - 620
  • [35] TACE combined with apatinib for the treatment of BCLC stage C of hepatocellular carcinoma: A restrospective controlled study
    Kan, Xuefeng
    Xiong, Bin
    Wang, Yong
    Liang, Bin
    Zhou, Guofeng
    Zheng, Chuansheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [36] Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study
    Yanyan Cao
    Tao Ouyang
    Fu Xiong
    Xuefeng Kan
    Lei Chen
    Bin Liang
    Chuansheng Zheng
    Hepatology International, 2021, 15 : 1268 - 1277
  • [37] Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    Chen, Qizhong
    MEDICINE, 2018, 97 (21)
  • [38] Transarterial Chemoembolization plus Radiotherapy vs. Transarterial Chemoembolization Alone for Single Hepatocellular Carcinoma within BCLC Stage 0-A
    Lee, H. I.
    Yoon, S. M.
    Jung, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E460 - E460
  • [39] Transarterial chemoembolization treatment in the management of BCLC c stage hepatocellular carcinoma: A large real-world observational study of 885 cases
    Yin, Xin
    Tang, Bei
    Yuan, Jia
    Li, Miao
    Zhang, Boheng
    Gan, Yu-Hong
    Wang, Yan-hong
    Ge, Ning-lin
    Chen, Yi
    Chen, Rong-xin
    Li, Li-Xin
    Yang, Bi-Wei
    Zhang, Lan
    Xue, Tong-chun
    Ren, Zhenggang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug-eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    Chen, Chuanben
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 482 - 489
12345